In a candid conversation with Prasad Sanyal, Group Business Head of TOI, Abdul Majeed, Chairman of Hamdard Laboratories India, shared insights into the development of sugar-free medicines and the resilience of Unani medicine in the country. He highlighted that India is the diabetic capital of the world, making the need for such innovations critical.
The Inspiration Behind Sugar-Free Medicines
Majeed recalled a conversation with his grandfather about how Unani medicine managed to survive and thrive in India. This heritage inspired Hamdard to create sugar-free alternatives, addressing the growing health crisis of diabetes. The company's efforts align with the rising demand for healthier options among Indian consumers.
Unani Medicine's Legacy
Unani medicine, rooted in Greek and Islamic traditions, has been practiced in India for centuries. Majeed emphasized that Hamdard has modernized these ancient remedies without compromising their core principles. The development of sugar-free medicines is a testament to this blend of tradition and innovation.
India's Diabetes Epidemic
With over 77 million diabetics, India faces a severe public health challenge. Majeed noted that dietary habits, including high sugar consumption, are major contributors. Hamdard's sugar-free line aims to provide effective treatments without exacerbating blood sugar levels.
Future Plans
Hamdard plans to expand its research into other lifestyle diseases, leveraging Unani principles. Majeed stressed the importance of integrating traditional knowledge with modern science to offer holistic healthcare solutions.
